Medication info
Exmet 50/850 mg

Exmet 50/850 mg

Prescription medicationTablet경구
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
주식회사제뉴원사이언스
Appearance
Dark pink oval film-coated tablet
Packaging
56 tablets/box [14 tablets/PTP×4], 30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 202204571 · Approved 2022.12.21 · Insurance code 671707260

Summary

Main use
Improvement of blood sugar control in Type 2 diabetes
Who takes it
Adults
Adult dose
This medication is typically taken twice a day with food and the dosage is gradually increased to minimize gastrointestinal side effects caused by metformin. 1. For patients not currently being treated with metformin: The initial dose of this drug 50/500 mg is 1 tablet twice daily, and can be increased to 1 tablet twice daily of 50/1000 mg. 2. For patients currently receiving metformin treatments:

Ingredients

Manufacturer
주식회사제뉴원사이언스

Efficacy & effects

Improvement of blood sugar control in Type 2 diabetes

View approved original text

This medication is used in combination with sitagliptin and metformin, designed to assist in blood sugar control for patients with Type 2 diabetes. It effectively lowers blood sugar levels alongside diet and exercise therapy, thus serving as a good treatment option for patients struggling with blood sugar management.

How to take

Adult dose

This medication is typically taken twice a day with food and the dosage is gradually increased to minimize gastrointestinal side effects caused by metformin. 1. For patients not currently being treated with metformin: The initial dose of this drug 50/500 mg is 1 tablet twice daily, and can be increased to 1 tablet twice daily of 50/1000 mg. 2. For patients currently receiving metformin treatments:

Precautions

This medication contains two components, sitagliptin and metformin, primarily used for blood sugar control in Type 2 diabetes patients. During the usage of this medication, severe allergic reactions may occur; if symptoms such as skin rash, hives, or difficulty breathing develop, discontinue use immediately and consult a doctor. There is a risk of acute pancreatitis, so if symptoms such as abdominal pain, nausea, or vomiting occur, notify healthcare personnel right away. Severe side effects like hypoglycemia or lactic acidosis may arise, thus this medication should not be used, especially by patients with impaired kidney function or liver dysfunction. In cases of poor kidney function or acute illness, or around the time of surgery, the use of this medication should be temporarily halted and may be reinitiated only after kidney function recovers to normal. This medication is not recommended for use during pregnancy or breastfeeding, and its safety and efficacy in pediatric patients under 18 years of age have not been established. Regular blood sugar and kidney function tests are necessary during treatment, and since vitamin B12 deficiency may occur, regular blood tests are advised. Excessive alcohol consumption can increase the risk of lactic acidosis; hence, avoiding alcohol is advisable. When used in conjunction with other hypoglycemic agents, particularly insulin or sulfonylurea medications, the risk of hypoglycemia may increase, necessitating dose adjustment. If severe joint pain or skin blistering occurs during medication, consult a physician immediately, and medication may need to be discontinued. It is important to consistently maintain diet and exercise therapy while taking this medication and to regularly consult healthcare professionals to monitor treatment effects and side effects.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (angioedema), anaphylaxis, rash, exfoliative skin diseases (including Stevens-Johnson syndrome), severe allergic reaction, acute pancreatitis (including hemorrhagic or necrotizing types), acute kidney failure, difficulty breathing, severe hypoglycemia, severe joint pain with disability, blistering dermatitis, liver abnormalities (increased liver enzymes, risk of jaundice), lactic acidosis, serious neurological symptoms (headache, confusion, etc.), hypertension

Mild side effects

  • Diarrhea
  • upper respiratory tract infection
  • headache
  • nausea
  • vomiting
  • abdominal pain
  • nasopharyngitis
  • constipation
  • myalgia
  • limb pain
Show 9 more
  • back pain
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • itching
  • dizziness
  • reduced appetite
  • weight loss
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is advisable to keep it at room temperature between 1°C and 30°C. This helps to maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

Dark pink oval film-coated tablet

Package unit

56 tablets/box [14 tablets/PTP×4], 30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.